Maine and 30 Other States Share $58 Million in a Record Breaking Settlement with Merck Pharmaceutical Resolving a Three Year Investigation
Attorney General Steven Rowe today filed a stipulated judgment with Merck and Company, Inc. resolving a three-year investigation by 30 states concerning the company's deceptive promotion of the anti-inflammatory "Cox-2" drug Vioxx. In addition to a $58 million payment to the participating states, with Maine's share being $1.1 million the judgment filed in the Kennebec County Superior Court will restrict Merck's ability to deceptively promote other Merck products.